Page last updated: 2024-10-31

metoclopramide and Cancer of Nose

metoclopramide has been researched along with Cancer of Nose in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"Nude mice with xenografted squamous cell carcinoma where injected with cisplatin 5 mg/kg i."1.29Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue. ( Johnsson, A; Kjellén, E; Pero, R; Wennerberg, J, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnsson, A1
Kjellén, E1
Wennerberg, J1
Pero, R1

Other Studies

1 other study available for metoclopramide and Cancer of Nose

ArticleYear
Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
    Anti-cancer drugs, 1996, Volume: 7, Issue:4

    Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cisplatin; DNA Adducts; Drug Synergism; Female; Ki

1996